Sub menu

 
 

Documents released under Section 11C of the Freedom of Information Act 1982, Jul 2017 to Jun 2018

Last updated

The documents released under Section 11C of the Freedom of Information Act 1982 have been made available on this site in Portable Document Format (PDF). They are available for downloading and printing. If you require access to the documents in an alternative format please contact the FOI Contact Officer by emailing or calling the Department of Health on 1800 020 103 or 02 6289 1555.

Date of releaseFOI numberDocuments
29 June 2018FOI 313-1718

De-identified SAS application for Cefuroxime from 1 July 2016 to 30 June 2017

22 June and 25 July 2018FOI 229-1718

SMR L2 Back Glenoid Component

12 June 2018FOI 317-1718

Changes to the 'about consultation' webpage

4 June 2018FOI 281-1718

Special Access Scheme (SAS) indications

4 June 2018FOI 275-1718

The number and nature of all adverse event reports submitted for tafenoquine to the TGA adverse events database

15 May 2018FOI 284-1718

Consumer Medicine Information(CMI) and Product Information(PI) for Champix from 2007 until the end of 2009

14 May 2018FOI 285-1718

Quantity of Dermis tissue accessed for orthopaedic applications i.e. AlloPatch, Athroflex DFU, Cortiva Allograft Dermis and Graft Jacket via the Special Access Scheme for the years 2016 and 2017

4 May 2018FOI 282-1718

Special Access Scheme Category B sodium benzoate & sodium phenylbutyrate in 2017

26 April 2018FOI 205-1718

Documents regarding a fungal contamination

3 May 2018 and 14 June 2018FOI 200-1718

Cost of advertising related committees

5 April 2018FOI 132-718

Historic PI & CMI for nasal spray products

29 March 2018FOI 140-1718

Policy and legal grounds for refusal of information regarding complaints

27 March 2018FOI 207-1718

Documents relating to FOI280-1617 (SAS B Applications for Tetracycline 500mg).

26 March 2018FOI 231-1718

SAS Category B applications & approvals, and SAS Category C notifications received for Cinnarizine

19 March 2018FOI 171-1718

Irrelevant information redacted under section 22(1) of the FOI Act

26 February 2018FOI 136-1718

All complaints to the Minister of Health in relation to Champix, subsequently provided/forwarded to the TGA, during the period 01 January 2015 to 20 December 2017, excluding any correspondence concerning adverse reactions.

21 February 2018FOI 156-1718

Traditional Chinese Medicines permitted indications list

14 February 2018FOI 194-1718

List of AP and SAS approval notifications for Sodium Meta-Arsenite 2.5mg

1 February 2018FOI 121-1718

Documents relating to the Departments considerations of reforms to the regulation of aromatherapy products

24 January 2018FOI 116-1718

Hard Surface Disinfectants

24 January 2018FOI 150-1718

Product disclosure/disclaimer for certain HIV test kits and devices

12 January 2018FOI 135-1718

Historic public summaries of deregistered mesh devices

20 December 2017FOI 080-1718

TGA documents relating to determining the regulatory burden arising from recommendations of the Independent Panel Review of Medicines and Medical Devices Regulations (MMDR)

19 December 2017FOI 073-1718

Clinical data relating to Picato and Soolantra

18 December 2017FOI 082-1718

Clinical trial documents for Essure/STOP

13 December 2017FOI 065-1718

Historic Product Information and Consumer Medicine Information for Diprosone and Diprosone OV between 1 January 2003 and 30 December 2010

29 November 2017FOI 078-1718

Specific correspondence between the TGA and Janssen in relation to Protopic ointment

21 November 2017FOI 081-1718

Request for documents relating to the recall of Arthrex Swivelock Suture Anchors

9 November 2017FOI 059-1718

Clinical Evaluation Reports and recommendations or reviews by the Advisory Committee on Medical Devices for multiple medical devices

1 November 2017FOI 088-1718

Notifications processed under the Special Access Scheme for Category C for Pristinamycin and Fosfomycin between 1/1/10 - 12/10/17

13 October 2017FOI 043-1718

Documents regarding reform to the regulation of homeopathic products

19 September 2017FOI 025-1718

Product Information, public summary and AusPar (or equivalent) documents relating to Prevenar between 2001 and 2005

5 September 2017FOI 306-1617

Documents regarding a fungal contamination

1 September 2017FOI 323-1617

Registration and approval for Mefloquine

21 July 2017FOI 287-1617

Documents in relation to the proposal to modify the deferral period in relation to blood donation for all sexual based-activity from twelve months to six months (Blood Service Proposal)

1 Jul 2016 to 30 Jun 2017Documents released under Section 11C of the Freedom of Information Act 1982, Jul 2016 to Jun 2017
1 Jul 2015 to 30 Jun 2016Documents released under Section 11C of the Freedom of Information Act 1982, Jul 2015 to Jun 2016
1 Jul 2014 to 30 Jun 2015Documents released under Section 11C of the Freedom of Information Act 1982, Jul 2014 to Jun 2015
1 Jul 2013 to 30 Jun 2014Documents released under Section 11C of the Freedom of Information Act 1982, Jul 2013 to Jun 2014
1 Jul 2012 to 30 Jun 2013Documents released under Section 11C of the Freedom of Information Act 1982, Jul 2012 to Jun 2013
1 Jul 2011 to 30 Jun 2012Documents released under Section 11C of the Freedom of Information Act 1982, Jul 2011 to Jun 2012

*Large file warning: Attempting to open large files over the Internet within the browser window may cause problems. It is strongly recommended you download this document to your own computer and open from there.

Topics

Help us improve the Therapeutic Goods Administration site